Top Markets
#1 Akedo Akedo +63.85%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.67%
#4 Cross Cross +44.24%
#5 Black Phoenix Black Phoenix +34.14%
#6 Velvet Velvet +29.70%
#7 OVERTAKE OVERTAKE +26.36%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +14.57%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +12.55%
#10 Palladium Network Palladium Network +12.47%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Valion Bio, Inc. Valion Bio, Inc.

Valion Bio, Inc.

VBIO
Rank in Stocks #38930
Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead... Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.
Share Price
$0.1818
Market Cap
$752.91K
Change (1 day)
6.44%
Change (1 year)
-94.81%
Country
US
Trade Valion Bio, Inc. (VBIO)

Category

Healthcare
Operating Margin for Valion Bio, Inc. (VBIO)
Operating Margin as of 2026 TTM: 0.00%
According to Valion Bio, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Valion Bio, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.